GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Earnings per Share (Diluted)

Shandong Boan Biotechnology Co (HKSE:06955) Earnings per Share (Diluted) : HK$-0.26 (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Earnings per Share (Diluted)?

Shandong Boan Biotechnology Co's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.26.

Shandong Boan Biotechnology Co's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.26.

Shandong Boan Biotechnology Co's EPS without NRI for the six months ended in Dec. 2023 was HK$0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.26.

During the past 3 years, the average EPS without NRIGrowth Rate was 23.40% per year.

During the past 4 years, Shandong Boan Biotechnology Co's highest 3-Year average EPS without NRI Growth Rate was 23.40% per year. The lowest was 23.40% per year. And the median was 23.40% per year.


Shandong Boan Biotechnology Co Earnings per Share (Diluted) Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Earnings per Share (Diluted) Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
-0.56 -0.54 -0.75 -0.25

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial -0.23 -0.35 -0.39 -0.26 -

Competitive Comparison of Shandong Boan Biotechnology Co's Earnings per Share (Diluted)

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Boan Biotechnology Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's PE Ratio falls into.



Shandong Boan Biotechnology Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Shandong Boan Biotechnology Co's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-130.572-0)/509.278
=-0.26

Shandong Boan Biotechnology Co's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(0.149-0)/509.278
=0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Shandong Boan Biotechnology Co  (HKSE:06955) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Shandong Boan Biotechnology Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.
Executives
Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li 2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines